Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 90
Inquire Before Buying

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

Highlights

The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ 1139.5 million in 2022 and is anticipated to reach US$ 1993.7 million by 2029, witnessing a CAGR of 10.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.

The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Merck

- Sinovac

- Kangtai Bio

- CDIBP

- Walvax

Segment by Type

- Single Dose Vial

- Pre-filled Syringe

Segment by Application

- For Children (Over 2 Years Old)

- For Adult

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2023

Table of Contents
1 Evening Primrose Oil Market Overview
1.1 Product Overview and Scope of Evening Primrose Oil
1.2 Evening Primrose Oil Segment by Type
1.2.1 Global Evening Primrose Oil Market Value Comparison by Type (2023-2029)
1.2.2 Evening Primrose Oil (?- linolenic acid 9%)
1.2.3 Evening Primrose Oil (?- linolenic acid 10%)
1.2.4 Others
1.3 Evening Primrose Oil Segment by Application
1.3.1 Global Evening Primrose Oil Market Value by Application: (2023-2029)
1.3.2 Pharmaceutical Industry
1.3.3 Cosmetic Industry
1.3.4 Food and Health Industry
1.4 Global Evening Primrose Oil Market Size Estimates and Forecasts
1.4.1 Global Evening Primrose Oil Revenue 2018-2029
1.4.2 Global Evening Primrose Oil Sales 2018-2029
1.4.3 Global Evening Primrose Oil Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Evening Primrose Oil Market Competition by Manufacturers
2.1 Global Evening Primrose Oil Sales Market Share by Manufacturers (2018-2023)
2.2 Global Evening Primrose Oil Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Evening Primrose Oil Average Price by Manufacturers (2018-2023)
2.4 Global Evening Primrose Oil Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Evening Primrose Oil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Evening Primrose Oil, Product Type & Application
2.7 Evening Primrose Oil Market Competitive Situation and Trends
2.7.1 Evening Primrose Oil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Evening Primrose Oil Players Market Share by Revenue
2.7.3 Global Evening Primrose Oil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Evening Primrose Oil Retrospective Market Scenario by Region
3.1 Global Evening Primrose Oil Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Evening Primrose Oil Global Evening Primrose Oil Sales by Region: 2018-2029
3.2.1 Global Evening Primrose Oil Sales by Region: 2018-2023
3.2.2 Global Evening Primrose Oil Sales by Region: 2024-2029
3.3 Global Evening Primrose Oil Global Evening Primrose Oil Revenue by Region: 2018-2029
3.3.1 Global Evening Primrose Oil Revenue by Region: 2018-2023
3.3.2 Global Evening Primrose Oil Revenue by Region: 2024-2029
3.4 North America Evening Primrose Oil Market Facts & Figures by Country
3.4.1 North America Evening Primrose Oil Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Evening Primrose Oil Sales by Country (2018-2029)
3.4.3 North America Evening Primrose Oil Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Evening Primrose Oil Market Facts & Figures by Country
3.5.1 Europe Evening Primrose Oil Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Evening Primrose Oil Sales by Country (2018-2029)
3.5.3 Europe Evening Primrose Oil Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Evening Primrose Oil Market Facts & Figures by Country
3.6.1 Asia Pacific Evening Primrose Oil Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Evening Primrose Oil Sales by Country (2018-2029)
3.6.3 Asia Pacific Evening Primrose Oil Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Evening Primrose Oil Market Facts & Figures by Country
3.7.1 Latin America Evening Primrose Oil Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Evening Primrose Oil Sales by Country (2018-2029)
3.7.3 Latin America Evening Primrose Oil Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Evening Primrose Oil Market Facts & Figures by Country
3.8.1 Middle East and Africa Evening Primrose Oil Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Evening Primrose Oil Sales by Country (2018-2029)
3.8.3 Middle East and Africa Evening Primrose Oil Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Evening Primrose Oil Sales by Type (2018-2029)
4.1.1 Global Evening Primrose Oil Sales by Type (2018-2023)
4.1.2 Global Evening Primrose Oil Sales by Type (2024-2029)
4.1.3 Global Evening Primrose Oil Sales Market Share by Type (2018-2029)
4.2 Global Evening Primrose Oil Revenue by Type (2018-2029)
4.2.1 Global Evening Primrose Oil Revenue by Type (2018-2023)
4.2.2 Global Evening Primrose Oil Revenue by Type (2024-2029)
4.2.3 Global Evening Primrose Oil Revenue Market Share by Type (2018-2029)
4.3 Global Evening Primrose Oil Price by Type (2018-2029)
5 Segment by Application
5.1 Global Evening Primrose Oil Sales by Application (2018-2029)
5.1.1 Global Evening Primrose Oil Sales by Application (2018-2023)
5.1.2 Global Evening Primrose Oil Sales by Application (2024-2029)
5.1.3 Global Evening Primrose Oil Sales Market Share by Application (2018-2029)
5.2 Global Evening Primrose Oil Revenue by Application (2018-2029)
5.2.1 Global Evening Primrose Oil Revenue by Application (2018-2023)
5.2.2 Global Evening Primrose Oil Revenue by Application (2024-2029)
5.2.3 Global Evening Primrose Oil Revenue Market Share by Application (2018-2029)
5.3 Global Evening Primrose Oil Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Henry Lamotte
6.1.1 Henry Lamotte Corporation Information
6.1.2 Henry Lamotte Description and Business Overview
6.1.3 Henry Lamotte Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Henry Lamotte Evening Primrose Oil Product Portfolio
6.1.5 Henry Lamotte Recent Developments/Updates
6.2 Connoils
6.2.1 Connoils Corporation Information
6.2.2 Connoils Description and Business Overview
6.2.3 Connoils Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Connoils Evening Primrose Oil Product Portfolio
6.2.5 Connoils Recent Developments/Updates
6.3 Omeganz
6.3.1 Omeganz Corporation Information
6.3.2 Omeganz Description and Business Overview
6.3.3 Omeganz Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Omeganz Evening Primrose Oil Product Portfolio
6.3.5 Omeganz Recent Developments/Updates
6.4 Baxco
6.4.1 Baxco Corporation Information
6.4.2 Baxco Description and Business Overview
6.4.3 Baxco Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxco Evening Primrose Oil Product Portfolio
6.4.5 Baxco Recent Developments/Updates
6.5 Plimon Group
6.5.1 Plimon Group Corporation Information
6.5.2 Plimon Group Description and Business Overview
6.5.3 Plimon Group Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Plimon Group Evening Primrose Oil Product Portfolio
6.5.5 Plimon Group Recent Developments/Updates
6.6 Efamol
6.6.1 Efamol Corporation Information
6.6.2 Efamol Description and Business Overview
6.6.3 Efamol Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Efamol Evening Primrose Oil Product Portfolio
6.6.5 Efamol Recent Developments/Updates
6.7 Sanmark
6.6.1 Sanmark Corporation Information
6.6.2 Sanmark Description and Business Overview
6.6.3 Sanmark Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanmark Evening Primrose Oil Product Portfolio
6.7.5 Sanmark Recent Developments/Updates
6.8 Jilin Shengji
6.8.1 Jilin Shengji Corporation Information
6.8.2 Jilin Shengji Description and Business Overview
6.8.3 Jilin Shengji Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jilin Shengji Evening Primrose Oil Product Portfolio
6.8.5 Jilin Shengji Recent Developments/Updates
6.9 Jilin Baili
6.9.1 Jilin Baili Corporation Information
6.9.2 Jilin Baili Description and Business Overview
6.9.3 Jilin Baili Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jilin Baili Evening Primrose Oil Product Portfolio
6.9.5 Jilin Baili Recent Developments/Updates
6.10 Liaoning Jiashi
6.10.1 Liaoning Jiashi Corporation Information
6.10.2 Liaoning Jiashi Description and Business Overview
6.10.3 Liaoning Jiashi Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Liaoning Jiashi Evening Primrose Oil Product Portfolio
6.10.5 Liaoning Jiashi Recent Developments/Updates
6.11 Hebei Xinqidian
6.11.1 Hebei Xinqidian Corporation Information
6.11.2 Hebei Xinqidian Evening Primrose Oil Description and Business Overview
6.11.3 Hebei Xinqidian Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hebei Xinqidian Evening Primrose Oil Product Portfolio
6.11.5 Hebei Xinqidian Recent Developments/Updates
6.12 Jilin Shangjia
6.12.1 Jilin Shangjia Corporation Information
6.12.2 Jilin Shangjia Evening Primrose Oil Description and Business Overview
6.12.3 Jilin Shangjia Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jilin Shangjia Evening Primrose Oil Product Portfolio
6.12.5 Jilin Shangjia Recent Developments/Updates
6.13 Dalian Tianshan
6.13.1 Dalian Tianshan Corporation Information
6.13.2 Dalian Tianshan Evening Primrose Oil Description and Business Overview
6.13.3 Dalian Tianshan Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Dalian Tianshan Evening Primrose Oil Product Portfolio
6.13.5 Dalian Tianshan Recent Developments/Updates
6.14 Yuanhua Biotechnology
6.14.1 Yuanhua Biotechnology Corporation Information
6.14.2 Yuanhua Biotechnology Evening Primrose Oil Description and Business Overview
6.14.3 Yuanhua Biotechnology Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yuanhua Biotechnology Evening Primrose Oil Product Portfolio
6.14.5 Yuanhua Biotechnology Recent Developments/Updates
6.15 Pioneer Herb
6.15.1 Pioneer Herb Corporation Information
6.15.2 Pioneer Herb Evening Primrose Oil Description and Business Overview
6.15.3 Pioneer Herb Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pioneer Herb Evening Primrose Oil Product Portfolio
6.15.5 Pioneer Herb Recent Developments/Updates
6.16 Panjin Green Bio-tec
6.16.1 Panjin Green Bio-tec Corporation Information
6.16.2 Panjin Green Bio-tec Evening Primrose Oil Description and Business Overview
6.16.3 Panjin Green Bio-tec Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Panjin Green Bio-tec Evening Primrose Oil Product Portfolio
6.16.5 Panjin Green Bio-tec Recent Developments/Updates
6.17 Shenzhen Kangerjian
6.17.1 Shenzhen Kangerjian Corporation Information
6.17.2 Shenzhen Kangerjian Evening Primrose Oil Description and Business Overview
6.17.3 Shenzhen Kangerjian Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Shenzhen Kangerjian Evening Primrose Oil Product Portfolio
6.17.5 Shenzhen Kangerjian Recent Developments/Updates
6.18 Shanghai Yanxintang
6.18.1 Shanghai Yanxintang Corporation Information
6.18.2 Shanghai Yanxintang Evening Primrose Oil Description and Business Overview
6.18.3 Shanghai Yanxintang Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shanghai Yanxintang Evening Primrose Oil Product Portfolio
6.18.5 Shanghai Yanxintang Recent Developments/Updates
6.19 Honsea
6.19.1 Honsea Corporation Information
6.19.2 Honsea Evening Primrose Oil Description and Business Overview
6.19.3 Honsea Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Honsea Evening Primrose Oil Product Portfolio
6.19.5 Honsea Recent Developments/Updates
6.20 Panjin Tianyuan Pharmaceutical
6.20.1 Panjin Tianyuan Pharmaceutical Corporation Information
6.20.2 Panjin Tianyuan Pharmaceutical Evening Primrose Oil Description and Business Overview
6.20.3 Panjin Tianyuan Pharmaceutical Evening Primrose Oil Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Panjin Tianyuan Pharmaceutical Evening Primrose Oil Product Portfolio
6.20.5 Panjin Tianyuan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Evening Primrose Oil Industry Chain Analysis
7.2 Evening Primrose Oil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Evening Primrose Oil Production Mode & Process
7.4 Evening Primrose Oil Sales and Marketing
7.4.1 Evening Primrose Oil Sales Channels
7.4.2 Evening Primrose Oil Distributors
7.5 Evening Primrose Oil Customers
8 Evening Primrose Oil Market Dynamics
8.1 Evening Primrose Oil Industry Trends
8.2 Evening Primrose Oil Market Drivers
8.3 Evening Primrose Oil Market Challenges
8.4 Evening Primrose Oil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2024-2029)
Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sinovac Corporation Information
Table 76. Sinovac Description and Business Overview
Table 77. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 79. Sinovac Recent Developments/Updates
Table 80. Kangtai Bio Corporation Information
Table 81. Kangtai Bio Description and Business Overview
Table 82. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 84. Kangtai Bio Recent Developments/Updates
Table 85. CDIBP Corporation Information
Table 86. CDIBP Description and Business Overview
Table 87. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 89. CDIBP Recent Developments/Updates
Table 90. Walvax Corporation Information
Table 91. Walvax Description and Business Overview
Table 92. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 94. Walvax Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 100. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 101. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 102. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2022 & 2029
Figure 4. Single Dose Vial Product Picture
Figure 5. Pre-filled Syringe Product Picture
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2022 & 2029
Figure 8. For Children (Over 2 Years Old)
Figure 9. For Adult
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) & (2018-2029)
Figure 14. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2022
Figure 18. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2018-2029)
Figure 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2018-2029)
Figure 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2029)
Figure 58. 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain
Figure 59. 23-Valent Pneumococcal Polysaccharide Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • 2023-2031 Report on Global Encephalitis Vaccination Market by Player, Region, Type, Application and Sales Channel
    Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 92
    This report studies the Encephalitis Vaccination market, covering market size for segment by type (Encephalitis B Vaccine, Encephalitis Attenuated Live Vaccine, etc.), by application (Hospitals, Other Medical Institutions, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, Sanofi, Chengdu institute of biologica, Wuhan Institute of Biological, Lanzhou Institute of Biological, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East ......
  • 2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel
    Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 87
    This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Avian Influenza ......
  • Global H1N1 Vaccines Market Research Report 2023
    Published: 07-Mar-2023        Price: US 2900 Onwards        Pages: 90
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Highlights The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2022 and is anticipated to reach US$ 5708.3 million by 2029, witnessing a CAGR of 3.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were co......
  • Global Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 02-Mar-2023        Price: US 3260 Onwards        Pages: 95
    The Pneumococcal Polysaccharide Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of Pneumococcal Polysaccharide Vaccine. The report also introduces players in the industry from the perspective of the......
  • Global H1N1 Vaccines Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Feb-2023        Price: US 3260 Onwards        Pages: 119
    The H1N1 Vaccines market revenue was 3150.1 Million USD in 2022, and will reach 28411.32 Million USD in 2028, with a CAGR of 44.28% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the H1N1 Vaccines industry, and breaks down according to the type, application, and consumption area of H1N1 Vaccines. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the......
  • Global Encephalitis Vaccine Market Research Report 2023
    Published: 07-Feb-2023        Price: US 2900 Onwards        Pages: 98
    Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. Highlights The global Encephalitis Vaccine market was valued at US$ 1291.2 million in 20......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 31-Jan-2023        Price: US 3450 Onwards        Pages: 113
    The report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in th......
  • Global Avian Influenza Vaccines Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 10-Jan-2023        Price: US 3450 Onwards        Pages: 125
    Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. The report focuses on the Avian Influenza Vaccines market size, segment size (mainly covering product type, application, an......
  • 2022-2030 Report on Global Avian Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Jan-2023        Price: US 2500 Onwards        Pages: 110
    This report studies the Avian Influenza Vaccine market, covering market size for segment by type (H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, QYH Biotech, DHN, HVRI, CEVA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs